Doxorubicin Hydrochloride
NDC 72603-103, Doxorubicin Hydrochloride, injectable, liposomal, from NorthStar RxLLC.
- Product NDC
- 72603-103
- Status
- Listed
- Labeler
- NorthStar RxLLC
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203263
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72603-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXORUBICIN HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72603-103-01 | 72603010301 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-103-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ddf55319-bf62-4ec7-8be2-ef97188837c4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72603-103
Use it
Look up 72603-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72603-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72603-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.